TEVA PHARMACEUTICAL INDUSTRIES LTD. Trademarks
Address: Please login to see owner's address
Entity Type: Corporation
Approximately 10 trademarks found.
TEVACANN
Cannabis based preparations for human use and products containing cannabis for human use namely, oral drops for pain, medicated oils; dietary...
Current Owner: Teva Pharmaceutical Industries LTD
Status: RESPONSE AFTER NON-FINAL ACTION - ENTERED
Filed on: 2022-02-04
ATTENUKINE
Pharmaceutical preparations for the treatment of cancer and autoimmune diseases
Current Owner: Teva Pharmaceutical Industries Ltd.
Status: NOTICE OF ALLOWANCE - ISSUED
Filed on: 2022-01-06
TEVADAPTOR2
Medical apparatus, namely, vial adaptors, bag adaptors, syringe adaptors, converters, connectors and parts and accessories therefor, for compounding...
Current Owner: Teva Pharmaceutical Industries Ltd
Status: ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Filed on: 2021-12-02
DDI+
COMPUTER SOFTWARE FOR PROVIDING GUIDANCE TO PHYSICIANS AND PHARMACISTS REGARDING HOW TO TREAT PATIENTS CONSUMING MULTIPLE MEDICATIONS IN A SAFER...
Current Owner: Teva Pharmaceutical Industries Ltd.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2011-02-01
TEVASTIM
pharmaceutical preparations, namely, filgastrim, a recombinant human GCSF (granulocyte colony-stimulating factor) for use in the treatment of...
Current Owner: TEVA Pharmaceutical Industries Ltd.
Status: CANCELLED - SECTION 8
Filed on: 2006-02-23
GRANULOSTIM
Pharmaceutical preparations, namely, filgastrim, a recombinant human GCSF (granulocyte colony-stimulating factor) for use in the treatment of...
Current Owner: TEVA Pharmaceutical Industries Ltd.
Status: CANCELLED - SECTION 8
Filed on: 2006-02-23
TEVAGRASTIM
pharmaceutical preparations, namely, filgastrim, a recombinant human GCSF (granulocyte colony-stimulating factor) for use in the treatment of...
Current Owner: TEVA Pharmaceutical Industries Ltd.
Status: CANCELLED - SECTION 8
Filed on: 2006-02-23
PURINETHOL ACCESS PROGRAM (MERCAPTOPURINE)
A prescription benefit program, which works with doctors to enroll low-income patients to get medication mailed directly without cost
Current Owner: TEVA Pharmaceutical Industries, Ltd.
Status: ABANDONED - EXPRESS
Filed on: 2003-11-05
PURINETHOL ACCESS PROGRAM (MERCAPTOPURINE)
A prescription benefit program, which works with doctors to enroll low-income patients to get medication mailed directly without cost
Current Owner: TEVA Pharmaceutical Industries, Ltd.
Status: ABANDONED - EXPRESS
Filed on: 2003-11-05
PROTECTED
Oral drug delivery formulations for use in treating Osteoporosis, Urinary Incontinence, Spasticity, and Neuropathic pain
Current Owner: Teva Pharmaceutical Industries, Ltd.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2002-10-16
